The European Medicines agency is reporting there is no evidence to support restricting the use of the AstraZeneca vaccine for any age group.
A growing list of countries have joined Germany in limiting the use of the jab over blood clot concerns.
Europe's drug regulator is investigating around 62 clotting cases worldwide.
